Vanguard Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$322M Buy
7,218,530
+7,033
+0.1% +$400K 0.01% 846
2026
Q2
$572M Buy
7,211,497
+93,167
+1% +$7.01M 0.01% 659
2026
Q1
$535M Buy
+7,118,330
New +$562M 0.01% 649

Other funds holding IONS

Vanguard Capital Management's IONS Position: Q3 2026 in Review

Vanguard Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 0.1% in Q3 2026, buying an estimated $400K and bringing the position to 7,218,530 shares worth $322M. The position accounts for 0.01% of the portfolio, ranked #846.

Vanguard Capital Management first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $572M in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Vanguard Capital Management held 7,218,530 shares of Ionis Pharmaceuticals worth $322M as of Q3 2026.
  • Vanguard Capital Management bought 7,033 Ionis Pharmaceuticals shares in Q3 2026, an estimated $400K.
  • Ionis Pharmaceuticals made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #846 holding.
  • Vanguard Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Ionis Pharmaceuticals position peaked at $572M in Q2 2026.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.